Navigation Links
Adeona Announces Positive Alzheimer's Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy
Date:6/2/2011

As prospectively hypothesized, patients administered reaZin demonstrated increased serum zinc levels and decreased serum free copper levels, resulting in statistical significance of the primary outcomes of the clinical study (p < 0.0006). The cognitive function of the placebo group, on average, declined over 6 months in comparison to patients managed with reaZin. The cognitive function trends favoring the patients managed with reaZin were observed in all three standardized cognitive tests utilized in our study and suggest that reaZin may provide an important benefit to the dietary management of zinc deficiency associated with Alzheimer's disease.

About reaZin

reaZin is a proprietary, gastroretentive, sustained release, once-daily oral tablet formulated from zinc (150 mg) and cysteine (100 mg), an amino acid with potent anti-oxidant properties. reaZin was developed by Adeona to achieve the following: 1) the convenience of a once-daily dose, 2) high oral bioavailability (the quantity or fraction of the ingested dose that is absorbed by the body) and 3) superior tolerability which provides the ability to minimize the substantial gastrointestinal side effects and limitations associated with existing oral zinc therapy.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company's primary strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is developing, or has partnered the development of, the following product candidates: a prescription medical food for the dietary management of zinc deficiency associated with Alzheimer's disease, and drugs to treat multiple sclerosis, fibromyalgia, Alzheimer's disease and a
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
2. Adeonas Multiple Sclerosis Clinical Trial Receives $1,594,553 Grant
3. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
4. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. Anesiva Announces Second Quarter 2008 Financial Results and Update
7. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
8. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
9. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
11. ThirdBiotech Announces Kemeta as Newest Sponsor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Global ... in-depth study on the current state of the Trifluoroacetic ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/27/2014)... 27, 2014  A novel biomarker for rheumatoid ... better identify early-stage disease, when treatment can often ... a new study in The Journal of Rheumatology. ... DGX ) and other institutions found that ... conventional antibody-serum testing, including rheumatoid factor (RF) and ...
(Date:8/27/2014)... Westminster, CO (PRWEB) August 27, 2014 ... image analysis services to the pharmaceutical and medical ... and expansion. The fast growing company has consolidated ... in Aurora and Boulder to Westminster, CO, just north ... and Histology Lab, 7575 W. 103rd Ave., Suite 100, ...
(Date:8/27/2014)... 2014 Tris Pharma, a specialty pharmaceutical company ... that it has been selected as an award winner ... 2014 Awards for Excellence competition in the Business ... of judges from SCORE (Counselors to America,s Small Business) ... honored at a gala event to be held on ...
Breaking Biology Technology:Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Flagship Biosciences Announces Relocation and Expansion 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2
... Pa., Aug. 24 MEDRAD, Inc. has signed a ... to study the impact of automated Fluoro-deoxy-glucose (FDG) administration ... procedures. Clinicians at Moffitt Cancer Center in Tampa, ... measure and infuse patient-specific FDG doses while industrial engineers ...
... , , SAN DIEGO, Aug. ... today announced that Mark Booth has joined the Company as ... of commercial and business development experience to Orexigen. Most ... (TPNA) where he presided over the commercial, medical and scientific ...
... , KVISTGAARD, Denmark, August ... that the US authorities have initiated,negotiations for a ... the,IMVAMUNE(R) smallpox vaccine. This potential new project will ... Advanced Research and,Development Authority) contract for the procurement ...
Cached Biology Technology:MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 4Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE(R) 2
(Date:8/27/2014)... getting effective doses of the HIV drug maraviroc, a ... studies, completed before the drug was licensed in 2007, ... is key to removing maraviroc from the body. The ... the protein including nearly half of African-Americans ... to those who lack the protein even when given ...
(Date:8/27/2014)... grass species frequently found in forests has created a ... American toads, a new University of Georgia study has ... the U.S. in the early 1900s, is one of ... more than a dozen states in the past century, ... in forests, it can survive in widely diverse ecosystems ...
(Date:8/27/2014)... what is described by the Volunteer Wildfire Services of ... Cape provincial government warned residents in certain parts of ... veld fires. A high veld fire danger rating ... coast in the Great Kei and Mnquma area. ... thunderstorms. The thunderstorms bring lightning strikes and subsequent ...
Breaking Biology News(10 mins):Dosage of HIV drug may be ineffective for half of African-Americans 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3
... great mysteries of life is how it began. What physical process ... a living cell? For more than a century, scientists have ... life. Until recently, their focus has been trained on how the ... early Earth, or perhaps in space. But because it happened so ...
... firing in a brain reward circuit instantly rendered mice ... a study supported by the National Institutes of Health ... mimic the pattern, previously resilient mice instantly succumbed to ... they avoided other animals and lost their sweet ...
... of Notre Dame biochemist Anthony S. Serianni is providing ... and treating diabetes. Serianni points out that biological ... human body from the natural breakdown of the simple ... in diabetic patients because glucose concentrations in the blood ...
Cached Biology News:ASU researchers propose new way to look at the dawn of life 2ASU researchers propose new way to look at the dawn of life 3Stress-resilience/susceptibility traced to neurons in reward circuit 2Stress-resilience/susceptibility traced to neurons in reward circuit 3Stress-resilience/susceptibility traced to neurons in reward circuit 4Notre Dame research may have important implications for combating diabetes 2
... centrifugal filters are disposable microfiltration devices for the ... the range 100 l to 500 l. They ... 2.2 ml centrifuge tubes. Product Features: ... Low hold up volume ( Fast ...
... The ClearSpin Filter is a novel disposable ... the clarification of bacterial lysates in plasmid ... is a novel, disposable spin filtration device ... bacterial lysates in plasmid purification procedures. The ...
... fixed-angle microcentrifuge rotor at RCF up ... filters consist of a membrane-containing filter ... filter by centrifugation for bacteria removal, ... of cells from media and DNA ...
... C, 0.7 mm depth • Reusable, press-to-seal ... be quickly assembled and disassembled for hybridizing ... of any thickness with up to a ... chambers per slide. Minimize specimen handling, eliminate ...
Biology Products: